Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | IAPP | P10997 | 2/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3280370 | 0.83 | ALDH1A1 (0.50) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL28769426 | 0.81 | KMT2A (0.39) | ALDH1A1TDP1TSHR | |
| SCHEMBL12424396 | 0.81 | TDP1 (0.47) | ALDH1A1TDP1FFAR3IAPPTSHR | |
| SCHEMBL16725017 | 0.81 | TDP1 (0.47) | ALDH1A1TDP1FFAR3IAPP | |
| SCHEMBL3279761 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TDP1HMGCRCHRM1TBXA2R | |
| SCHEMBL31016294 | 0.78 | TDP1 (0.50) | ALDH1A1TDP1FFAR3IAPP | |
| SCHEMBL27511799 | 0.77 | TDP1 (0.43) | ALDH1A1TDP1FFAR3IAPP | |
| SCHEMBL21078338 | 0.77 | TDP1 (0.43) | ALDH1A1TDP1FFAR3IAPP | |
| SCHEMBL17481554 | 0.75 | ACLY (0.42) | ALDH1A1TDP1FFAR3CHRM1ADRA1A | |
| SCHEMBL8896096 | 0.75 | TDP1 (0.41) | ALDH1A1TDP1FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2640403-B1 | GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS | ACCELERATED BIOSCIENCES CORP (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20240426829-A1 | COMPOSITIONS AND METHODS FOR THE DETECTION OF BRAIN INJURY | CHILDRENS HOSPITAL PHILADELPHIA (US) | 2024-12-26 | — | — | US | disclosed |
| US-20240124839-A1 | GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS | ACCELERATED BIOSCIENCES CORP. | 2024-04-18 | — | — | US | disclosed |
| US-20240085413-A1 | METHODS, DEVICES AND COMPOSITIONS FOR THE DISCRIMINATION OF PATHOGENS BASED ON PATTERNS OF VOLATILE COMPOUNDS | MONELL CHEMICAL SENSES CENTRE (US) | 2024-03-14 | — | — | US | disclosed |
| US-11891623-B2 | Generation of neural stem cells from human trophoblast stem cells | ACCELERATED BIOSCIENCES CORP. (US) | 2024-02-06 | — | — | US | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220267724-A1 | GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS | ACCELERATED BIOSCIENCES CORP. | 2022-08-25 | — | — | US | disclosed |
| WO-2022159381-A1 | METHODS, DEVICES AND COMPOSITIONS FOR THE DISCRIMINATION OF PATHOGENS BASED ON PATTERNS OF VOLATILE COMPOUNDS | MONELL CHEMICAL SENSES CENTER (US) | 2022-07-28 | — | — | WO | disclosed |
| US-20020098497-A1 | Use of human phermone polypeptides | LOK SI (US) | 2002-07-25 | — | — | US | disclosed |
| WO-2002042464-A2 | HUMAN V2 VOMERONASAL RECEPTOR | ZYMOGENETICS, INC. (US) | 2002-05-30 | — | — | WO | disclosed |
| WO-2002023201-A2 | USE OF HUMAN PHERMONE POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 2002-03-21 | — | — | WO | disclosed |
| WO-2002020612-A2 | HUMAN VOMERONASAL RECEPTOR-3 | ZYMOGENETICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002020761-A2 | HUMAN VOMERONASAL RECEPTOR-4 | ZYMOGENETICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002020760-A2 | HUMAN VOMERONASAL RECEPTOR | ZYMOGENETICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002020651-A2 | HUMAN PHERMONE POLYPEPTIDE | ZYMOGENETICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002020597-A2 | HUMAN VOMERONASAL RECEPTOR-5 | ZYMOGENETICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002018571-A2 | HUMAN PHERMONE POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| WO-2002010386-A2 | HUMAN VOMERONASAL RECEPTOR | ZYMOGENETICS, INC. (US) | 2002-02-07 | — | — | WO | disclosed |